PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24414167-1	2014	INTRODUCTION: Studies have shown that ticagrelor has a further adenosine-mediated mechanism of action in addition to its potent inhibition of the P2Y12 receptor, which may explain some of ticagrelor"s clinical characteristics.	Ticagrelor	38-48	purinergic receptor P2Y12	Canis lupus familiaris	146-151